Fang Ni
2023
In 2023, Fang Ni earned a total compensation of $1.5M as Chief Business Officer and Interim Chief Financial Officer at Black Diamond Therapeutics, a 64% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $189,361 |
|---|---|
| Option Awards | $823,542 |
| Salary | $450,865 |
| Other | $25,758 |
| Total | $1,489,526 |
Ni received $823.5K in option awards, accounting for 55% of the total pay in 2023.
Ni also received $189.4K in non-equity incentive plan, $450.9K in salary and $25.8K in other compensation.
Rankings
In 2023, Fang Ni's compensation ranked 802nd out of 3,006 executives tracked by ExecPay. In other words, Ni earned more than 73.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 802 out of 3,006 | 73rd |
Division Manufacturing | 471 out of 1,650 | 72nd |
Major group Chemicals And Allied Products | 321 out of 918 | 65th |
Industry group Drugs | 313 out of 881 | 65th |
Industry Biological Products, Except Diagnostic Substances | 99 out of 213 | 54th |
Source: SEC filing on April 24, 2024.
Ni's colleagues
We found three more compensation records of executives who worked with Fang Ni at Black Diamond Therapeutics in 2023.